Motterlini, Roberto <br/><br/>
HYCO-3, a dual CO-releaser/Nrf2 activator, reduces tissue inflammation in mice challenged with lipopolysaccharide.  [electronic resource] 

 -  Redox biology  01 2019 
 - 334-348 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2213-2317 
<br/><br/><label>Standard No.: </label>10.1016/j.redox.2018.10.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents--pharmacology<br/>Antioxidants--metabolism<br/>Carbon Monoxide--metabolism<br/>Cells, Cultured<br/>Cytokines--genetics<br/>Disease Models, Animal<br/>Gene Expression<br/>Heme Oxygenase-1--genetics<br/>Inflammation--drug therapy<br/>Inflammation Mediators--metabolism<br/>Lipopolysaccharides--adverse effects<br/>Macrophages--drug effects<br/>Male<br/>Mice<br/>Mice, Knockout<br/>Microglia--drug effects<br/>NF-E2-Related Factor 2--genetics<br/>Oxidative Stress--drug effects